Again, I specifically refer to 2 current directors, one who had responsibilities at the FDA previously and another who would have plenty of experience with FDA from his previous roles.I would be very surprised if they each were not directly involved and influenced high level FDA meetings in their respective areas for MSB. At a very minimum, they have capacity to understand and access all relevant company records for these 2 indications with respect to outstanding FDA issues.
Again, I specifically refer to 2 current directors, one who had...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.000(0.00%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.08 | $5.380M | 4.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 69437 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 19999 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |